Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review
M Amoroso, S Augustin, S Moosmang… - Journal of Molecular …, 2024 - Springer
Liver cirrhosis due to nonalcoholic steatohepatitis (NASH) is a life-threatening condition with
increasing incidence world-wide. Although its symptoms are unspecific, it can lead to …
increasing incidence world-wide. Although its symptoms are unspecific, it can lead to …
[HTML][HTML] Serum zinc level and dietary zinc intake status in non-alcoholic fatty liver disease: A meta-analysis and systematic review
Materials and Methods A systematic search was performed in PubMed, Web of Science, and
Scopus databases for relevant English articles with mean/standard deviation values of …
Scopus databases for relevant English articles with mean/standard deviation values of …
[HTML][HTML] Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
BF Yan, LF Pan, YF Quan, Q Sha… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological entity
characterized by intrahepatic ectopic steatosis. As a consequence of increased consumption …
characterized by intrahepatic ectopic steatosis. As a consequence of increased consumption …
Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of …
FS Fan - Tumor Biology, 2023 - content.iospress.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to low-density lipoprotein (LDL)
receptor and fatty acid translocase CD36, inducing lysosomal degradation of these two …
receptor and fatty acid translocase CD36, inducing lysosomal degradation of these two …
[HTML][HTML] Evaluation of the impact of metabolic syndrome on fibrosis in metabolic dysfunction-associated fatty liver disease
HT Kani, CO Demirtas, C Keklikkiran… - The Turkish Journal …, 2021 - ncbi.nlm.nih.gov
Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and
the individual impact of these disorders on metabolic dysfunction-associated fatty liver …
the individual impact of these disorders on metabolic dysfunction-associated fatty liver …
[HTML][HTML] Feasibility of Fibroscan in assessment of hepatic steatosis and fibrosis in obese patients: report from a general internal medicine clinic
Background In metabolic associated fatty liver disease (MAFLD) vibration controlled
transient elastography (VCTE) by Fibroscan has emerged as a non-invasive diagnostic tool …
transient elastography (VCTE) by Fibroscan has emerged as a non-invasive diagnostic tool …
[HTML][HTML] The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
1Department of Gastroenterology, Recep Tayyip Erdogan University School of Medicine,
Rize, Turkiye; 2Institute of Gastroenterology, Marmara University, Istanbul, Turkiye; 3Section …
Rize, Turkiye; 2Institute of Gastroenterology, Marmara University, Istanbul, Turkiye; 3Section …
Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study
M Gumussoy, O Koc, G Karatas… - European journal of …, 2022 - journals.lww.com
Methods Between 15 January 2001 and 14 March 2021, a total of 1365 patients had been
diagnosed with NAFLD were enrolled in the study. Results The median follow-up period was …
diagnosed with NAFLD were enrolled in the study. Results The median follow-up period was …
[HTML][HTML] Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
BB Karaoğlan, C Tulunay, Ç Uzun, E Peker… - The Turkish Journal …, 2023 - ncbi.nlm.nih.gov
Background: The aims of the present study were to determine the subclinical coronary
atherosclerosis and myocardial dysfunction in patients with non-alcoholic fatty liver disease …
atherosclerosis and myocardial dysfunction in patients with non-alcoholic fatty liver disease …
Identification of Fatty acid metabolism-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Nonalcoholic fatty liver disease
X Xie, T Xiong, Y Zhai, X Liu, W Song, M Gao, X He… - 2024 - researchsquare.com
Aim To elucidate the regulatory mechanisms of fatty acid metabolism-related genes
(FAMRGs) and the gene expression clustering in nonalcoholic fatty liver disease (NAFLD) …
(FAMRGs) and the gene expression clustering in nonalcoholic fatty liver disease (NAFLD) …